Davis Polk advised the joint book-running managers and representatives of the underwriters in the offering. Bristol-Myers Squibb Company executed its public debt offering, consisting of $1.5…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
